Straightforward, laboratory-based biochemical tests that measure marke
rs of bone resorption in urine have substantially increased the inform
ation available for the management of patients at risk of bone loss, T
hese tests can help to identify patients most suitable for interventio
n with anti-resorptive therapy to halt bone loss, and the subsequent m
onitoring of therapeutic efficacy. A number of urinary bone resorption
markers are available; each measures different substances and can var
y in tissue specificity, metabolic process specificity and susceptibil
ity to metabolic influences. Total variability of an assay derives bot
h from the analytical characteristics of the assay and the biological
variability of the measured analyte. This paper summarizes research on
the components of analytical and biological variability for three bon
e resorption markers.